| Dr Anne O Rodriguez, MD | |
|
2900 Loma Vista Rd Ste 205, Ventura, CA 93003-2909 | |
| (805) 642-4830 | |
| (805) 642-3852 |
| Full Name | Dr Anne O Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 33 Years |
| Location | 2900 Loma Vista Rd Ste 205, Ventura, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316929565 | NPI | - | NPPES |
| 00G846780 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | G84678 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Barbara Cottage Hospital | Santa barbara, CA | Hospital |
| Community Memorial Hospital San Buenaventura | Ventura, CA | Hospital |
| Goleta Valley Cottage Hospital | Santa barbara, CA | Hospital |
| Entity Name | County Of San Joaquin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801830583 PECOS PAC ID: 6002703436 Enrollment ID: O20040301001287 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
| Entity Name | Gynecologic Oncology Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386770725 PECOS PAC ID: 5890710560 Enrollment ID: O20051011001207 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
| Entity Name | San Joaquin Faculty Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225063761 PECOS PAC ID: 4082631395 Enrollment ID: O20051026000742 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
| Entity Name | Lompoc Valley Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649282856 PECOS PAC ID: 9739275595 Enrollment ID: O20090506000381 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
| Entity Name | Cottage Clinical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235790544 PECOS PAC ID: 0345625950 Enrollment ID: O20220919001496 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne O Rodriguez, MD 2900 Loma Vista Rd Ste 205, Ventura, CA 93003-2909 Ph: (805) 642-4830 | Dr Anne O Rodriguez, MD 2900 Loma Vista Rd Ste 205, Ventura, CA 93003-2909 Ph: (805) 642-4830 |
News Archive
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.
This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.
› Verified 1 days ago
John Charles Gustafson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2795 Loma Vista Rd, Ventura, CA 93003 Phone: 805-643-8695 Fax: 805-643-2087 | |
Dr. Kathryn Jones Sharma, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1591 Spinnaker Dr. Suite 201, Ventura, CA 93001 Phone: 805-515-3121 Fax: 805-620-7862 | |
Dr. Roy Schneider, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 888 S Hill Rd, Ventura, CA 93003 Phone: 805-477-6464 Fax: 805-477-6498 | |
Michael Rotas, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 200 S Wells Rd Ste 200, Ventura, CA 93004 Phone: 805-659-1740 | |
Dr. Srisawai Pattamakom, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2945 Loma Vista Rd, Ventura, CA 93003 Phone: 805-677-8003 Fax: 805-677-8404 | |
Tajinder Bir Kaur, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2921 Saviers Road, Ventura, CA 93030 Phone: 805-487-5588 Fax: 805-487-5589 | |
Dr. Lois Barnes, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 168 N Brent St Ste 302, Ventura, CA 93003 Phone: 805-652-6373 |